Export 2409 results:
[ Author(Desc)] Title Type Year
Filters: Filter is   [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Costa, E., Rocha, S., Rocha-Pereira, P., Reis, F., et al. (2008). DMT1 (NRAMP2/DCT1) Genetic Variability and Resistance to Recombinant Human Erythropoietin Therapy in Chronic Kidney Disease Patients under Haemodialysis. Acta Haematologica, 120(1), 11 - 13.
Costa, C., & Vendeira, P. (2007). The penis and endothelium. Extragenital aspects of erectile dysfunction. O pénis e o endotélio. Aspectos extra genitais da disfunção eréctilRevista Internacional de Andrologia, 5(1), 50 - 58.
Costa, M., Cruz, E., Oliveira, S., Benes, V., et al. (2015). Lymphocyte gene expression signatures from patients and mouse models of hereditary hemochromatosis reveal a function of hfe as a negative regulator of cd8+ t-Lymphocyte activation and differentiation in vivo. PLoS ONE, 10(4).
Costa, E., Swinkels, D. W., Laarakkers, C. M., Rocha-Pereira, P., et al. (2009). Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients. Acta Haematologica, 122(4), 226 - 229.
Costa, C., Incio, J., & Soares, R. (2007). Angiogenesis and chronic inflammation: Cause or consequence?. Angiogenesis, 10(3), 149 - 166.
Costa, F., Carvalho, I. F., Montelaro, R. C., Gomes, P., & Martins, M. C. L. (2011). Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces. Acta Biomaterialia, 7(4), 1431 - 1440.
Costa, R., Gonçalves, A., Saraiva, M. J., & Cardoso, I. (2008). Transthyretin binding to A-Beta peptide - Impact on A-Beta fibrillogenesis and toxicity. FEBS Letters, 582(6), 936 - 942.
Costa, E., Rocha, S., Rocha-Pereira, P., Nascimento, H., et al. (2008). Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients. American Journal of Nephrology, 28(6), 935 - 940.
Costa, E., Pereira, B. J. G., Rocha-Pereira, P., Rocha, S., et al. (2008). Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients. American Journal of Nephrology, 28(4), 677 - 683.
Costa, M. A., Fonseca, B. M., Keating, E., Teixeira, N. A., & Correia-da-Silva, G. (2014). 2-Arachidonoylglycerol effects in cytotrophoblasts: Metabolic enzymes expression and apoptosis in BeWo cells. Reproduction, 147(3), 301 - 311.
Costa, R., Ferreira-Da-Silva, F., Saraiva, M. J., & Cardoso, I. (2008). Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: A mechanism sensitive to the kunitz protease inhibitor. PLoS ONE, 3(8).
Costa, R., Speretta, E., Crowther, D. C., & Cardoso, I. (2011). Testing the therapeutic potential of doxycycline in a Drosophila melanogaster model of Alzheimer disease. Journal of Biological Chemistry, 286(48), 41647 - 41655.
Costa, M. M. R., Hilliou, F., Duarte, P., Pereira, L. G., et al. (2008). Molecular cloning and characterization of a vacuolar class III peroxidase involved in the metabolism of anticancer alkaloids in Catharanthus roseus. Plant Physiology, 146(2), 403 - 417.
Costa, E., Lima, M., Rocha, S., Rocha-Pereira, P., et al. (2008). IL-7 serum levels and lymphopenia in hemodialysis patients, non-responders to recombinant human erythropoietin therapy. Blood Cells, Molecules, and Diseases, 41(1), 134 - 135.
Costa, M. D. C., Magalhães, P., Guimarães, L., MacIel, P., et al. (2006). The CAG repeat at the Huntington disease gene in the Portuguese population: Insights into its dynamics and to the origin of the mutation. Journal of Human Genetics, 51(3), 189 - 195.
Costa, M. D. C., Teixeira-Castro, A., Constante, M., Magalhães, M., et al. (2006). Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype. Journal of Human Genetics, 51(8), 645 - 651.
Costa, E., Coimbra, J., Catarino, C., Ribeiro, S., et al. (2012). Major determinants of BMP-2 serum levels in hemodialysis patients. Renal Failure, 34(10), 1355 - 1358.
Costa, V., Quintanilha, A., & Moradas-Ferreira, P. (2007). Protein oxidation, repair mechanisms and proteolysis in Saccharomyces cerevisiae. IUBMB Life, 59(4-5), 293 - 298.
Costa, M. A., Keating, E., Fonseca, B. M., Teixeira, N. A., & Correia-da-Silva, G. (2015). 2-Arachidonoylglycerol impairs human cytotrophoblast cells syncytialization: Influence of endocannabinoid signalling in placental development. Molecular and Cellular Endocrinology, 399, 386 - 394.
Costa, E., Lima, M., Alves, J. M., Rocha, S., et al. (2008). Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. Journal of Clinical Immunology, 28(3), 268 - 275.
Costa, E., Rocha, S., Rocha-Pereira, P., Castro, E., et al. (2008). Changes in red blood cells membrane protein composition during hemodialysis procedure. Renal Failure, 30(10), 971 - 975.
Costa, E., Rocha, S., Rocha-Pereira, P., Castro, E., et al. (2008). Cross-talk between inflammation, coagulation/fibrinolysis and vascular access in hemodialysis patients. Journal of Vascular Access, 9(4), 248 - 253.
da Costa, J. P., Carvalhais, V., Ferreira, R., Amado, F., et al. (2015). Proteome signatures—how are they obtained and what do they teach us?. Applied Microbiology and Biotechnology, 99(18), 7417 - 7431.
Costa Lima, S., Rodrigues, V., Garrido, J., Borges, F., et al. (2012). In vitro evaluation of bisnaphthalimidopropyl derivatives loaded into pegylated nanoparticles against Leishmania infantum protozoa. International Journal of Antimicrobial Agents, 39(5), 424 - 430.
da Costa Tavares, J. A. P., Ouaissi, A., & Cordeiro-da-Silva, A. (2008). Therapy and further development of anti-leishmanial drugs. Current Drug Therapy, 3(3), 204 - 208.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@i3s.up.pt | © copyright 2010 ibmc